$16.52
4.73%
Nasdaq, Sep 28, 04:17 pm EDT. Closed.
ISIN
US21874A1060
Symbol
CORZ
Industry

Core Scientific Target price 2026 - Analyst rating & recommendation

Core Scientific Classifications & Recommendation

Buy
88%
Hold
12%

Core Scientific Price Target

Target Price $35.70
Price $16.52
Potential
Number of Estimates 21
21 Analysts have issued a price target Core Scientific 2027 . The average Core Scientific target price is $35.70. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 26 analysts: 23 Analysts recommend Core Scientific to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Core Scientific stock has an average upside potential 2027 of . Most analysts recommend the Core Scientific stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 319.02 689.04
37.53% 115.99%
EBITDA Margin -48.79% 34.14%
346.72% 169.98%
Net Margin -88.00% -48.82%
63.91% 44.52%

20 Analysts have issued a sales forecast Core Scientific 2026 . The average Core Scientific sales estimate is

$689m
unlock
. This is
56.49% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$809m 83.69%
unlock
, the lowest is
$596m 35.39%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $319m 37.53%
2026
$689m 115.99%
unlock
2027
$1.2b 67.48%
unlock
2028
$1.7b 46.88%
unlock
2029
$2.8b 67.20%
unlock
2030
$4.0b 39.98%
unlock

20 Analysts have issued an Core Scientific EBITDA forecast 2026. The average Core Scientific EBITDA estimate is

$235m
unlock
. This is
332.20% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$373m 467.72%
unlock
, the lowest is
$157m 255.13%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-156m 254.13%
2026
$235m 251.14%
unlock
2027
$667m 183.37%
unlock
2028
$1.1b 65.62%
unlock
2029
$1.4b 23.73%
unlock
2030
$1.8b 31.33%
unlock

EBITDA Margin

2025 -48.79% 346.72%
2026
34.14% 169.98%
unlock
2027
57.76% 69.19%
unlock
2028
65.13% 12.76%
unlock
2029
48.20% 25.99%
unlock
2030
45.22% 6.18%
unlock

19 Core Scientific Analysts have issued a net profit forecast 2026. The average Core Scientific net profit estimate is

$-336m
unlock
. This is
75.67% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$37.3m 102.69%
unlock
, the lowest is
$-561m 59.44%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-281m 77.46%
2026
$-336m 19.82%
unlock
2027
$86.7m 125.77%
unlock
2028
$153m 76.73%
unlock

Net Margin

2025 -88.00% 63.91%
2026
-48.82% 44.52%
unlock
2027
7.51% 115.38%
unlock
2028
9.04% 20.37%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -0.88 -1.05
81.93% 19.32%
P/E negative
EV/Sales 11.37

19 Analysts have issued a Core Scientific forecast for earnings per share. The average Core Scientific EPS is

$-1.05
unlock
. This is
75.35% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$0.12 102.82%
unlock
, the lowest is
$-1.75 58.92%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.88 81.93%
2026
$-1.05 19.32%
unlock
2027
$0.27 125.71%
unlock
2028
$0.48 77.78%
unlock

P/E ratio

Current -3.88 93.79%
2026
-15.70 304.86%
unlock
2027
60.91 487.96%
unlock
2028
34.46 43.42%
unlock

Based on analysts' sales estimates for 2026, the Core Scientific stock is valued at an EV/Sales of

11.37
unlock
and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 17.80 10.29%
2026
11.37 36.10%
unlock
2027
6.79 40.29%
unlock
2028
4.62 31.92%
unlock
2029
2.77 40.19%
unlock
2030
1.98 28.56%
unlock

P/S ratio

Current 12.06 18.37%
2026
7.70 36.10%
unlock
2027
4.60 40.29%
unlock
2028
3.13 31.92%
unlock
2029
1.87 40.19%
unlock
2030
1.34 28.56%
unlock

Current Core Scientific Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
UBS
Locked
➜
Locked
Locked Sep 23 2026
Rothschild & Co
Locked
➜
Locked
Locked Sep 21 2026
Wells Fargo
Locked
➜
Locked
Locked Sep 17 2026
B. Riley Securities
Locked
➜
Locked
Locked Aug 03 2026
Keefe, Bruyette & Woods
Locked
➜
Locked
Locked Jul 30 2026
Macquarie
Locked
➜
Locked
Locked Jul 29 2026
Canaccord Genuity
Locked
➜
Locked
Locked Jul 29 2026
Analyst Rating Date
Locked
UBS:
Locked
➜
Locked
Sep 23 2026
Locked
Rothschild & Co:
Locked
➜
Locked
Sep 21 2026
Locked
Wells Fargo:
Locked
➜
Locked
Sep 17 2026
Locked
B. Riley Securities:
Locked
➜
Locked
Aug 03 2026
Locked
Keefe, Bruyette & Woods:
Locked
➜
Locked
Jul 30 2026
Locked
Macquarie:
Locked
➜
Locked
Jul 29 2026
Locked
Canaccord Genuity:
Locked
➜
Locked
Jul 29 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today